Published in Blood Weekly, September 29th, 2005
According to recent research published in the journal Annals of Hematology, "Leukemias have traditionally served as model systems for research on neoplasia because of the easy availability of cell material from blood and marrow for diagnosis, monitoring and studies on pathophysiology. Beyond these more technical aspects, CML became the first neoplasia in which the elucidation of the genotype led to a rationally designed therapy of the phenotype."
"Targeting of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.